Skip to main content

Home/ Stock Market Traders/ Group items tagged Dendreon

Rss Feed Group items tagged

Brian Plain

DNDN Options Trading Dendreon FDA has approved PROVENGE Stock Trading Video - 1 views

  •  
    Dendreon Provenge Approval Call Summary (45.50 +5.88) -Update : During the call, the co said that it will provide Provenge to 2000 patients in next 12 months. Co said that demand for Provenge will exceed co's ability to provide it in the first 12 months; will continue build out of manufacturing capabilities. Mgmt said that 1 infusion will cost $31k; complete course will cost $93k. and EPS of $1.65.
1 - 1 of 1
Showing 20 items per page